Press Releases

Year

Mar 2012

LifeVantage Makes a Charitable Donation of $50,000 to Wells of Life

SALT LAKE CITY , March 26, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that it has donated funds to build water wells in East Africa , which could provide clean water to approximately 100,000

PDF Version

Feb 2012

LifeVantage Announces Record Second Quarter Fiscal Year 2012

Net Revenue Increases 239% Over Prior Year Period to $25.3 Million Operating Income Improves to a Record $4.3 Million Company Raises Full Year Fiscal 2012 Revenue and Operating Margin Guidance SALT LAKE CITY , Feb. 14, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of

PDF Version

Feb 2012

LifeVantage Spokesperson, Donny Osmond, Appears on Dr. Phil

Protandim Ranks First Among U.S. Google Searches

PDF Version

Feb 2012

LifeVantage to Announce Fiscal Second Quarter 2012 Results on February 14, 2012

SALT LAKE CITY , Feb. 7, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today it will release financial results for the second quarter ended December 31, 2011 , after the market closes on Tuesday,

PDF Version

Jan 2012

LifeVantage Expands Board of Directors and Announces Approval of Tender Offer to Modify Warrants

Nine Directors Including Four New Directors Elected at Company's Annual Meeting of Shareholders Board Appoints New Chairman SALT LAKE CITY , Jan. 17, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced that

PDF Version

Jan 2012

LifeVantage to Present at 14th Annual ICR XChange

SALT LAKE CITY , Jan. 4, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson , the Company's President and Chief Executive Officer, will be presenting at the 14th Annual ICR

PDF Version

Dec 2011

LifeVantage Provides Corporate Update

Announces Adoption of Rule 10b5-1 Stock Repurchase Plan Anticipates Approval of Warrant Amendment to Remove Price-Based Anti-dilution Provisions Outlines Operational & Strategic Accomplishments and Guidance for 2012 SALT LAKE CITY , Dec. 19, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation

PDF Version

Nov 2011

LifeVantage to Present at Wedbush 12th Annual California Dreamin' Conference

SALT LAKE CITY , Nov. 30, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson , the Company's President and Chief Executive Officer, and Carrie McQueen , the Company's Chief

PDF Version

Nov 2011

LifeVantage Announces Record First Quarter Fiscal Year 2012 Results

Net Revenue Increases Over 200% from the Prior Year Period to $20.1 Million Operating Income Improves to a Record $3.4 Million or 17% Operating Margin Company Raises Full Year Fiscal 2012 Revenue and Operating Margin Guidance SALT LAKE CITY , Nov. 14, 2011 (GLOBE NEWSWIRE) -- LifeVantage

PDF Version

Nov 2011

LifeVantage Announces New Peer-Reviewed Study Involving Protandim(R)

Published in Scientific Journal Molecular Aspects of Medicine

PDF Version

Pagination

First page
Previous page
…
Page 29
Page 30
Page 31
Page 32
Current page 33
Page 34
Page 35
Page 36
Page 37
…
Next page
Last page